At a glance
ClinicalIndex Comparison RecordN/ACompleted· 197 enrolled
Drug / intervention
Pipeline™ Embolization Device/ Pipeline™Flex Embolization Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Study on Embolization of Intracranial Aneurysms With the Pipeline™ Device (PREMIER)
In Brief
A clinical study evaluating Pipeline™ Embolization Device/ Pipeline™Flex Embolization Device for Intracranial Aneurysm. Completed, enrolled 197 participants across 23 sites in 2 countries.
Detailed Summary
The purpose of this study is to assess the safety and effectiveness of the Pipeline™ device in the treatment of unruptured, wide-neck intracranial aneurysms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntracranial Aneurysm
CountriesCanada, United States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 2014
Enrollment StartJul 2014
Primary CompletionNov 2016
Study CompletionDec 2018
TodayJul 2026
First PostedJul 10, 2014
Enrollment StartJul 24, 2014
Primary CompletionNov 18, 2016
Study CompletionDec 13, 2018
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.0 years ago
Interventions
Pipeline™ Embolization Device/ Pipeline™Flex Embolization Devicedevice